Protective effect of Bajijiasu against β-amyloid-induced neurotoxicity in pc12 cells

Cellular and Molecular Neurobiology

Volumn 33, Issue 6, 2013, Pages 837-850

  Chen, Di Ling ^a   Zhang, Peng ^b   Lin, Li ^b   Shuai, Ou ^b   Zhang, He Ming ^a   Liu, Song Hao ^a   Wang, Jin Yu ^b  

^a SOUTH CHINA NORMAL UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Amyloid; Alzheimer's disease; Bajijiasu; Neuroprotection; PC12 cells

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; BAJIJIASU; CALCIUM; CASPASE 3; CYCLIN DEPENDENT KINASE 4; FRUCTOSE; GLUTATHIONE REDUCTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; PROTEIN BAX; PROTEIN P21; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DISACCHARIDE; E2F1 PROTEIN, RAT; FRUCTOFURANOSYL-(2-2)-FRUCTOFURANOSYL; HERBACEOUS AGENT; NEUROPROTECTIVE AGENT; NEUROTOXIN;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE DEPOLARIZATION; CELL VIABILITY; CONTROLLED STUDY; DRUG STRUCTURE; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PC12 CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; CELL DEATH; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; PC12 CELL LINE; PROTEIN QUATERNARY STRUCTURE; RAMAN SPECTROMETRY; RAT; SIGNAL TRANSDUCTION; TIME; TOXICITY;

MORINDA OFFICINALIS;

AMYLOID BETA-PEPTIDES; ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CALCIUM; CASPASE 3; CELL DEATH; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISACCHARIDES; DRUGS, CHINESE HERBAL; E2F1 TRANSCRIPTION FACTOR; MEMBRANE POTENTIAL, MITOCHONDRIAL; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NF-KAPPA B; OXIDATIVE STRESS; PC12 CELLS; PROTEIN STRUCTURE, QUATERNARY; RATS; SIGNAL TRANSDUCTION; SPECTRUM ANALYSIS, RAMAN; TIME FACTORS;

EID: 84881088507     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-013-9950-7     Document Type: Article

References (80)

1. Allen JW, Eldadah BA, Huang X, Knoblach SM, Faden AI (2001) Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis. J Neurosci Res 65:45-53
2. Baichwal VR, Baeuerle PA (1997) Activate NF-kappa B or die. Curr Biol 7:R94-R96
3. Ban T, Hamada D, Hasegawa K, Naiki H, Goto Y (2003) Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence. J Bio Chem 278:16462-16465
4. Baum L, Lam CW, Cheung SK, Kwok T, Liu V, Tsoh J, Lam L, Leung V, Hui E, Ng C, Woo J, Chiu HF, Goggins WB, Zee BC, Cheng KF, Fong CY, Wong A, Mok H, Chow MS, Ho PC, Ip SP, Ho CS, Yu XW, Lai CY, Chan MH, Szeto S, Chan IH, Mok V (2008) Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer's disease. J Clin Psychopharmacol 28:110-113
5. Beal MF (2005) Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58:495-505
6. Behl C, Davis J, Cole GM, Schubert D (1992) Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem Biophys Res Commun 186(2):944-950
7. Boehrer S, Chow KU, Beske F, Kukoc-Zivoinov N, Puccetti E, Ruthardt M, Baum C, Ranqnekar VM, Hoelzer D, Mitrou PS, Weidmann E (2000) In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation. Cancer Res 62:1768-1775
8. Bonavia R, Bajetto A, Barbero S, Albini A, Noonan DM, Schettini G (2001) HIV-1 Tat cause apoptotic death and calcium homeostasis alteration in rat neurons. Biochem Biophys Res Commun 288:301-308
9. Bond JP, Deverin SP, Inouye H, el-Agnaf OM, Teeter MM, Kirschner DA (2003) Assemblies of Alzheimer's peptides A beta 25-35 and A beta 31-35: reverse-turn conformation and side-chain interactions revealed by X-ray diffraction. J Struct Biol 141(2):156-170
10. Borroni B, Colciaghi F, Pastorino L et al (2001) Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetyl-cholinesterase inhibitor treatment. Arch Neurol 58(3):442-446
11. Butterfield DA, Reed T, Sultana R (2011) Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease. Free Radic Res 45:59-72
12. Chauhan V, Chauhan A (2006) Oxidative stress in Alzheimer's disease. Pathophysiology 13:195-208
13. Chen JX, Yan SD (2007) Pathogenic role of mitochondrial [correction of mitochondrial] amyloid-beta peptide. Expert Rev Neurother 7:1517-1525
14. Crack PJ, Taylor JM (2005) Reactive oxygen species and the modulation of stroke. Free Radic Biol Med 38:1433-1444
15. Cracon SI, Knapp MJ, Berghof WG et al (1998) Safety of tacrine: clinical trials, treatment IND, and postmarketing experience. Alzheimer Dis Assoc Disord 12:93-101
16. Cummings JL (2001) Alzheimer's disease. N Engl J Med 351:56-67
17. Deng SD, Xiao FX, Lin L, Zhang P, Lin JR, Zhang SB (2012) HILIC-eLSD determination of five oligosaccharides contained in Morinda officinalis. Zhongguo Zhong Yao Za Zhi 37(22):3446-3450
18. Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK (2006) Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 26:9057-9068
19. 25-35 injection into the temporal cortex induces chronic inflammation that contributes to neurodegeneration and spatial memory impairment in rats. J Alzheimers Dis 30:505-522
20. Eckert A, Hauptmann S, Scherping I, Rhein V, Müller-Spahn F, Götz J, Müller WE (2008) Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice. Neurodegener Dis 5:157-159
21. Fiers W, Beyaert R, Declercq W, Vandenabeele P (1999) More than one way to die: apoptosis and necrosis and reactive oxygen damage. Oncogene 18:7719-7730
22. Frost RL, Xi Y, Scholz R, Ribeiro C (2013) A The molecular structure of the phosphate mineral chalcosiderite-A vibrational spectroscopic study. Spectrochim Acta A Mol Biomol Spectrosc 111C:24-30
23. Gardner AM, Xu FH, Fady C, Jacoby FJ, Duffey DC, Tu Y, Lichtenstein A (1997) Apoptotic versus nonapoptotic cytotoxicity induced by hydrogen peroxide. Free Radic Biol Med 22:73-83
24. Hardy H (1997) Amyloid the presenilins and Alzheimer's disease. Trends Neurosci 20:154-159
25. Heldt CL, Kurouski D, Sorci M, Grafeld E, Lednev IK, Belfort G (2011) Isolating toxic insulin amyloid reactive species that lack β-sheets and have wide pH stability. Biophys J 100:2792-2800
26. Heo H, Kim DO, Choi SJ, Shin DH, Lee CY (2004) Potent inhibitory effect of flavonoids in Scutellaria baicalensis on amyloid β protein-induced neurotoxicity. J Agric Food Chem 52:4128-4132
27. Hu JF, Chu SF, Ning N, Yuan YH, Xue W, Chen NH, Zhang JT (2010) Protective effect of (-) clausenamide against Aβ-induced neurotoxicity in differentiated PC12 cells. Neurosci Lett 483:78-82
28. Huang HM, Ou HC, Hsieh SJ, Chiang LY (2000) Blockage of amyloid beta peptide-induced cytosolic free calcium by fullerenol-1, carboxylate C60 in PC12 cells. Life Sci 66:1525-1533
29. Huang SH, Lin CM, Chiang BH (2008) Protective effects of Angelica sinensis extract on amyloid b-peptide-induced neurotoxicity. Phytomedicine 15:710-721
30. Hudson SA, Ecroyd H, Kee1 TW and Carver JA (2009) The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. FEBS. doi: 10.1111/j.1742-4658.2009.07307.x
31. Iversen LL, Mortishire-Smith RJ, Pollack SJ, Shearman MS (1995) The toxicity in vitro of b-amyloid protein. Biochem J 311:1-16
32. Jay ME (2005) Cholinesterase inhibitors in the treatment of dementia. JAOA 105(3):145-158
33. 25-35. Exp Neurol 221:26-37
34. Katzman R, Saitoh T (1991) Advances in Alzheimer's disease. FASEB J 5:278-286
35. Knopman DS (2006) Current treatment of mild cognitive impairment and Alzheimer's disease. Curr Neurol Neurosci Rep 6:365-371
36. Kotchey GP, Gaugler JA, Kapralov AA, Kagan VE, Star A (2013) Effect of antioxidants on enzyme-catalysed biodegradation of carbon nanotubes. J Mater Chem B Mater Biol Med 1:302-309
37. Krishnan KR, Charles HC, Doraiswamy PM, Mintzer J, Weisler R, Yu X, Perdomo C, Ieni JR, Rogers S (2003) Randomized, placebo controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatry 160:2003-2011
38. Labbé JF, Lefèvre T, Guay-Bégin AA, Auger M (2013) Structure and membrane interactions of the β-amyloid fragment 25-35 as viewed using spectroscopic approaches. Phys Chem Chem Phys 15(19):7228-7239
39. Laczkó I, Holly S, Kónya Z, Soós K, Varga JL, Hollósi M, Penke B (1994) Conformational mapping of amyloid peptides from the putative neurotoxic 25-35 region. Biochem Biophys Res Commun 205(1):120-126
40. Lezoualc'h F, Sagara Y, Holsboer F, Behl C (1998) High constitutive NF-kappa B activity mediates resistance to oxidative stress in neuronal cells. J Neurosci 18:3224-3232
41. Li YF, Yuan L, Xu YK, Yang M, Zhao YM, Luo ZP (2001) Antistress effect of oligosaccharides extracted from Morinda officinalis in mice and rats. Acta Pharmacol Sin 22:1084-1088
42. Li YF, Liu YQ, Yang M, Wang HL, Huang WC, Zhao YM, Luo ZP (2004) The cytoprotective effect of inulin-type hexasaccharide extracted from Morinda officinalis on PC12 cells against the lesion induced by corticosterone. Life Sci 75:1531-1538
43. Li G, Ma R, Huang C, Tang Q, Fu Q, Liu H, Hu B, Xiang J (2008a) Protective effect of erythropoietin on β-amyloid-induced PC12 cell death through antioxidant mechanisms. Neurosci Lett 442:143-147
44. Li J, Zhang HL, Wang Z, Liang YM, Jiang L, Ma W, Yang DP (2008b) Determination content of the antidepressant extraction and analysis the trace elements from Morinda officinalis. Zhong Yao Cai 31(9):1337-1340
45. Liu R, Gao M, Qiang GF, Zhang TT, Lan X, Ying J, Du GH (2009a) The anti-amnesic effects of luteolin against amyloid beta(25-35) peptide-induced toxicity in mice involve the protection of neurovascular unit. Neuroscience 162:1232-1243
46. Liu XH, Xiao FX, Chen YG, Lin L, Lin SD, Qiu RH, Liu Z (2009b) Determination of Bajijiasu in Morinda officinalis how by HPLC-ELSD. Tradit Chin Drug Res Clin Pharmacol 20:446-448
47. 2+ antagonism. Phytother Res 25(5):681-685
48. McCollum AT, Nasr P, Estus S (2002) Calpain activates caspase-3 during UV-induced neuronal death but only calpain is necessary for death. J Neurochem 82:1208-1220
49. Meunier J, Ieni J, Maurice T (2006) The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. Br J Pharmacol 149:998-1012
50. Miller BC, Eckman EA, Sambamurti K, Dobbs N, Chow KM, Eckman CB, Hersh LB, Thiele DL (2003) Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci USA 100:6221-6226
51. Parker WD Jr, Fillery CM, Parks JK (1990) Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40:1302-1303
52. 2+ ATPase isoform 4b is cleaved and activated by caspase-3 during the early phase of apoptosis. J Biol Chem 277:6822-6829
53. Peng Y, Xing C, Xu S, Lemere CA, Chen G, Liu B, Wang L, Feng Y, Wang X (2009) l-3-n-butylphthalide improves cognitive impairment induced by intracerebroventricular infusion of amyloid-beta peptide in rats. Eur J Pharmacol 621:38-45
54. Perez MJ, Cederbaum AI (2003) Adenovirus-mediated expression of Cu/Zn- or Mn-superoxide dismutase protects against CYP2E1-dependent toxicity. Hepatology 38:1146-1158
55. Petersen A, Castilho RF, Hansson O, Wieloch T, Brundin P (2000) Oxidative stress, mitochondrial permeability transition and activation of caspases in calcium ionophore A23187-induced death of cultured striatal neurons. Brain Res 857:20-29
56. Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW (1995) Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem 64(1):253-265
57. Pudlas M, Koch S, Bolwien C, Walles H (2010) Raman spectroscopy as a tool for quality and sterility analysis for tissue engineering applications like cartilage transplants. Int J Artif Organs 33:228-237
58. Reiter RJ (1998) Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobio 56:359-384
59. Richard-Lacroix M, Pellerin C (2013) Novel method for quantifying molecular orientation by polarized Raman spectroscopy: a comparative simulations study. Appl Spectrosc 67:409-419
60. Sala SG, Muñoz U, Bartomé F, Bermejo F, Martín- Requero A (2008) HMG-CoA reductase inhibitor simvastatin inhibits cell cycle progression at the G1/S checkpoint in immortalized lymphocytes from Alzheimer's disease patients independently of cholesterol-lowering effects. J Pharmacol Exp Ther 324:352-359
61. Sánchez V, Redmann K, Wistuba J, Wübbeling F, Burger M, Oldenhof H, Wolkers WF, Kliesch S, Schlatt S, Mallidis C (2012) Oxidative DNA damage in human sperm can be detected by Raman microspectroscopy. Fertil Steril. 98:1124-1129.e1-3
62. Selkoe DJ (2000) Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann N Y Acad Sci 924:17-25
63. Siebenlist U, Franzoso G, Brown K (1994) Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10:405-455
64. Smith ZJ, Huser TR, Wachsmann-Hogiu S (2013) Raman scattering in pathology. Stud Health Technol Inform 185:207-234
65. Son J, Lee J, Lee M (2004) Rapid quantitative analysis of oxiracetam in human plasma by liquid chromatography/electrospray tandem mass spectrometry. J Pharm Biomed Anal 36:183-187
66. Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I, Memantine Study Group (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 291:317-324
67. 25-35-induced toxicity and oxidative stress in vivo: a potential role in Alzheimer's disease. Int J Neurosci 122:563-569
68. Walter J, Grunberg J, Schindzielorz A, Haass C (1998) Proteolytic fragments of the Alzheimer's disease associated presenilins-1 and -2 are phosphorylated in vivo by distinct cellular mechanisms. Biochemistry 37:5961-5967
69. Wang KY (2001) Carbohydrate-based drugs: outline and prospects. Pharm Biotechnol 8(6):345-347
70. Weidemann A, Paliga K, Durrwang U, Reinhard FB, Schuckert O, Evin G, Masters CL (1999) Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases. J Biol Chem 274:5823-5829
71. Winnicka K, Tomasiak M, Bielawska A (2005) Piracetam: an old drug with novel properties. Acta Pol Pharm 62(5):405-409
72. Wolfe Michael S (2001) Secretase targets for Alzheimer's disease: identification and therapeutic potential. Med Chem 44:2039-2060
73. Wolff C, Gillard M, Fuks B, Chatelain P (2005) [3H]linopirdine binding to rat brain membranes is not relevant for M-channel interaction. Eur J Pharmacol 518:10-17
74. Won-in K, Thongkam Y, Pongkrapan S, Intarasiri S, Thongleurm C, Kamwanna T, Leelawathanasuk T, Dararutana P (2011) Raman spectroscopic study on archaeological glasses in Thailand: ancient Thai glass. Spectrochim Acta A Mol Biomol Spectrosc 83:231-235
75. Yamada K, Nabeshima T (2000) Animal models of Alzheimer's disease and evaluation of anti-dementia drugs. Pharmacol Ther 88:93-113
76. Yang J, Feng G, Yu S, Qiao P (2010) Angiogenesis promoting effect of Morinda officinalis oligosaccharides on chicken embryo chorioallantoic membrane. Zhongguo Zhong Yao Za Zhi 35:360-363
77. Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250(4978):279-282
78. 25-35 peptide-induced mouse model of Alzheimer's disease. Eur J Pharmacol 704:70-77
79. Zhang HY, Liu YH, Wang HQ, Xu JH, Hu HT (2008) Puerarin protects PC12 cells against β-amyloid-induced cell injury. Cell Biol Int 32:1230-1237
80. Zhuang ZF, Li N, Gou ZY, Zhu MF, Xiong K, Chen SJ (2012) Study of molecule variations in renal tumor based on confocal micro-Raman spectroscopy. J Biomed Opt 18:031103